OBiO Technology Information

About OBiO OBiO Technology (Shanghai) Corp., Ltd. ('OBiO', SSE:688238.SH) is a gene and cell therapy-focused biotechnology company founded in 2013. In China for global customers, we offer holistic research, development, and manufacturing solutions for vectorology studies, functional genomics, process and analytical development, IND-enabling CMC, clinical and commercial manufacturing. With "enable gene therapy for better lives" as our mission, we are committed to providing high-quality service to global customers, advancing your product from bench to clinic, and bringing benefit to populations around the world. For more information about OBiO, visit www.obio-tech.com. Our Vision "Enable Gene Therapy For Better Lives" For detailed job opening information, please visit www.obio-tech.com. For business development, please contact bd@obiosh.com.

Website	http://www.obio-tech.com
Employees	25 (25 on RocketReach)
Founded	2013
Industry	Biotechnology
Keywords	Gene Therapy, Cell Therapy, Biotechnology, Cellular Therapies, Research Solutions, Development Solutions, Manufacturing Solutions, Drug Development, Gene Editing, Pharmaceutical Research, Medical Technology, Advanced Therapies, Pharmaceutical Manufacturing, Clinical Trials, Biologics Manufacturing, Immunotherapy, Regenerative Medicine, Precision Medicine, Bioprocessing
Competitors	Bio-Rad Laboratories, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, Inc., GE HealthCare, MilliporeSigma, Roche, Illumina, QIAGEN, BD +45 more (view full list)